At a glance
In this webinar, you will learn about ATSDR's public health mission and the process of conducting a public health assessment (PHA). The PHA is ATSDR's method for evaluating community exposures to hazardous substances at contaminated sites. You will also discover effective strategies for collaborating with communities and gathering the appropriate data for the PHA process.
Training objectives
At the conclusion of the Public Health Assessment Webinar: Introduction to ATSDR and the Public Health Assessment Process, you will be able to:
- Discuss how ATSDR performs the PHA process.
- Explain the environmental site roles of the ATSDR and the Environmental Protection Agency (EPA) when working together at Superfund sites.
- Identify how to work with the community throughout the PHA process.
- Discuss how to assess site data and information needed for the PHA process.
Target audience
Public health professionals involved or interested in the PHA process, including:
- Environmental Health Specialists, Toxicologists, and Epidemiologists
- Health Educators, Community Involvement Specialists, Health Communicators
- Medical Officers and Registered Nurses
- Program Managers
Continuing education units
Instructions for Obtaining Continuing Education (CE)
To receive continuing education (CE) for WD4741- Public Health Assessment Webinar: Introduction to ATSDR and the Public Health Assessment Process, you must complete the steps below by March 21, 2026. Use the "WD4741" course number to search for this course.
- Check the box for each type of CE you wish to apply for when registering for the course.
- Complete the course.
- If there is a Mark Completed button on the course page in TRAIN, click to move to the next step.
- Pass the post-assessment. You will have 2 attempts to pass.
- Complete the evaluation.
You can access your certificates and transcript by visiting Your Learning in TRAIN.
Prerequisites
There are no prerequisites for this webinar, but we recommend studying the Public Health Assessment Trainings Module 1, Module 2, and Module 3 before watching this presentation.
Faculty/Credentials
- Gregory M. Zarus, MS MS BS BS, Director of Office of Innovation and Analytics (OIA), ATSDR/OCHHA/OIA
- Sylvia Allen-Lewis, MA BA, Health Education Specialist, ATSDR/OCCHA/ADPPE
Accreditation Statements
CME (Continuing Medical Education): The Centers for Disease Control and Prevention designates this enduring activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE (Continuing Nursing Education): The Centers for Disease Control and Prevention designates this activity for 1.25 nursing contact hours.
CEU (Continuing Education Unit): The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU's for this program.
CECH (Continuing Education Contact Hours): Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 1.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 1.0. Continuing Competency credits available are 1.0. CDC provider number 98614.
CPH (Certified in Public Health): The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1.0 CPH recertification credits for this program.
Disclosure
CDC, our planners, and content experts wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use.
CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.